Home › Depression › NCT06091527
Treating Major Depression With Yoga Mono-therapy
Treating Major Depression With Yoga Mono-therapy: 12-Week Randomized Controlled Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion criteria: * 18 years of age or older * Able to give voluntary, informed consent * English-speaking * Diagnosis of clinical depression Exclusion criteria: * Current use of antidepressant medication * Current engagement in psychotherapy * Current pregnancy * Significant medical issues interfering with yoga practice
About the study
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
What is being tested
- Yoga practice (behavioral)
- Education (behavioral)
Sponsor: University of California, San Francisco · Participants: 180 · Started: Oct 25, 2024
Contact the study team
- Sudha Prathikanti, MD · Phone: 415-516-3867
Official record on ClinicalTrials.gov — NCT06091527
Locations in the U.S.
| California | Zuckerberg San Francisco General Hospital, San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.